Across TCGA pan-cancer cohorts, LINC01657 RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated LINC01657 data layer.
The strongest signal is observed in cholangiocarcinoma (CHOL), where higher LINC01657 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01657 expression acts as an unfavorable survival marker, although some lineages such as PAAD and CESC show a favorable association.
CHOL, ACC, and KICH are the cancer types where LINC01657 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.